22.12.2014 - Swiss pharmaceutical producer group Roche said it would discontinue a late-stage study of investigational anti-amyloid medicine gantenerumab in pre-dementia Alzheimer's disease...
Advertising Opportunities Print, Digital & Content Solutions
LinkedIn | X (Twitter)